LifyLact® Flor – Synbiotic + Lactulose Capsules

LifyLact® Flor is a next-generation synbiotic supplement, exclusively developed by FatahMed Pharma.

Its unique formula combines probiotic strains to stimulate intestinal peristalsis and prebiotic Lactulose Crystalline (Origin Italy) to soften stools naturally by increasing water absorption in the intestines.

Each box contains 20 capsules (650 mg each), offering a safe, effective, and non-habit forming solution for both occasional and chronic constipation
 


Improve Chronic Constipation

improve chronic constipation.

LifyLact Flor – Synbiotic Supplement with Lactulose for Constipation Relief | FatahMed Pharma

Supports normal intestinal movement (peristalsis) and helps reduce occasional constipation.

Helps rebalance and maintain a healthy intestinal flora.

Lactulose draws water into the bowel to soften stool and promote easier passage.

Natural and mild — a gentle approach compared with many chemical laxatives.

How to use

1–2 capsules daily (each capsule 650 mg), or follow your healthcare professional’s advice.Drink plenty of water while using the product — adequate fluid intake improves lactulose’s effectiveness and helps maintain healthy bowel function.

Safety & tolerability 
Probiotics and prebiotics are generally well tolerated. Some people may experience mild, temporary digestive changes (for example, slight bloating or gas) as the gut adjusts.

If you are taking prescription medications or have a serious medical condition, check with your healthcare professional before starting any supplement.

In pregnancy or breastfeeding, use only after consulting your healthcare provider.

Storage

Store in a cool, dry place (below 25°C). Protect from direct sunlight. Keep out of reach of children.
NoteThis product is a dietary supplement, not a medicine.

improve chronic constipation with LifyLact® Flor.

96%

Treating the chronic constipation, bloating and abdominal pain in adults and elderly

81%

Improving symptoms irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD)

76%

Improving glucose metabolism and decreasing fasting blood glucose, serum insulin and insulin resistance, especially in patients with type 2 diabetes mellitus.